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Background: While facing increasing anthelmintic resistance, knowledge about resistance mechanism becomes crucial. 
Despite its importance, for resistance to macrocyclic lactones this still remains unresolved. Non-specific mechanisms of 
resistance involving transporters, e.g. P-glycoproteins (Pgps), or inactivating enzymes, e.g. Cytochrome P450s (CyP450s), are 
believed to play an important role. Nematodes have a complex repertoire of both protein classes. It is currently unknown, which 
transporter or enzyme system is associated with resistance to certain anthelmintics. The cattle nematode Cooperia oncophora 
was used as a model to study contribution of both, CyP450s and two individual Pgps, to the development of resistance in more 
detail. 
Methods: The response of susceptible and ML-resistant isolates of C. oncophora to ivermectin were evaluated in vitro in the 
presence of Pgp and CyP450-inhibitors verapamil hydrochloride (VPL) and piperonyl butoxide (PBO), respectively,. Full-length 
Pgp cDNAs were cloned following amplification by RT-PCR and RACE-PCR. Sequence variation of two Pgps was compared 
between six C. oncophora isolates with different resistance status by SeqDoc-analysis. Inducibility of Pgp transcript level by 
ivermectin was analysed by real-time RT-PCR. 
Results: In the presence of VPL and PBO the susceptibility of all tested isolates to ivermectin was significantly increased in the 
in vitro assays measuring development (100-fold) or motility (10-fold). Comparison of full length Pgp-2 and Pgp-3 (currently 65% 
of the sequence analysed) sequences between C. oncophora isolates revealed no major differences correlating with resistance 
though sequence variability was generally lower in resistant isolates. Preliminary results indicate only minor differences in Pgp-2 
expression levels between C. oncophora isolates. Expression of Pgp-3 and inducibility of both Pgps by ivermectin are currently 
examined. 
Summary/Conclusions: Though these data indicate that degradation and extrusion as non-specific xenobiotic detoxification 
mechanisms are both involved in ivermectin-resistance in C. oncophora, identification of the relevant genes still remains problematic. 
The characterised panel of C. oncophora isolates nevertheless provides a useful tool for further analyses of specific Pgp and CyP450 
genes and their possible contribution to ivermectin efflux and metabolism. 
 
